Is apoCIII-Lowering A Double-Edged Sword?

J Atheroscler Thromb. 2022 Jul 1;29(7):1117-1124. doi: 10.5551/jat.LE002. Epub 2022 May 11.

Authors

Xiangming Tang¹, Huanjin Zhou², Haizhao Yan^{1

3}, Manabu Niimi¹, Jianglin Fan^{1

2}

Affiliations

¹ Department of Molecular Pathology, Faculty of Medicine, Interdisciplinary Graduate School of Medicine, University of Yamanashi.
² School of Biotechnology and Health Sciences, Wuyi University.
³ Key Laboratory of Regenerative Biology, South China Institute for Stem Cell, Biology and Regenerative Medicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences.

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Letter

MeSH terms

Apolipoprotein C-III*
Humans

Substances

Apolipoprotein C-III